Variant report

Variant	nsv825818
Chromosome Location	chr11:32849904-32852165
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr11:32850824-32851272	HepG2	liver:	n/a	n/a
2	ARID3A	chr11:32851965-32852404	HepG2	liver:	n/a	n/a
3	ATF2	chr11:32850720-32851321	GM12878	blood:	n/a	n/a
4	ATF2	chr11:32850594-32851339	GM12878	blood:	n/a	n/a
5	BRCA1	chr11:32851255-32851263	H1-hESC	embryonic stem cell:	n/a	n/a
6	BRCA1	chr11:32850715-32851268	Hela-S3	cervix:	n/a	n/a
7	BRCA1	chr11:32851524-32851531	GM12878	blood:	n/a	n/a
8	CEBPB	chr11:32851052-32852610	HCT-116	colon:	n/a	chr11:32852309-32852320 chr11:32852133-32852144 chr11:32852309-32852322
9	CEBPB	chr11:32850788-32851520	Hela-S3	cervix:	n/a	n/a
10	CEBPB	chr11:32852029-32852224	HepG2	liver:	n/a	chr11:32852133-32852144
11	CEBPB	chr11:32851911-32852361	ECC-1	luminal epithelium:	n/a	chr11:32852309-32852320 chr11:32852133-32852144 chr11:32852309-32852322
12	CEBPB	chr11:32851962-32852298	K562	blood:	n/a	chr11:32852133-32852144
13	CEBPB	chr11:32852047-32852201	K562	blood:	n/a	chr11:32852133-32852144
14	CEBPB	chr11:32851793-32852346	H1-hESC	embryonic stem cell:	n/a	chr11:32852309-32852320 chr11:32852133-32852144 chr11:32852309-32852322
15	CEBPB	chr11:32851907-32852432	A549	lung:	n/a	chr11:32852309-32852320 chr11:32852133-32852144 chr11:32852309-32852322
16	CEBPB	chr11:32851856-32852380	MCF-7	breast:	n/a	chr11:32852309-32852320 chr11:32852133-32852144 chr11:32852309-32852322
17	CEBPB	chr11:32851061-32851240	H1-hESC	embryonic stem cell:	n/a	n/a
18	CEBPB	chr11:32851870-32852240	HepG2	liver:	n/a	chr11:32852133-32852144
19	CEBPB	chr11:32851807-32852532	A549	lung:	n/a	chr11:32852309-32852320 chr11:32852133-32852144 chr11:32852309-32852322
20	CEBPB	chr11:32851950-32852328	IMR90	lung:	n/a	chr11:32852309-32852320 chr11:32852133-32852144 chr11:32852309-32852322
21	CEBPB	chr11:32851736-32852568	Hela-S3	cervix:	n/a	chr11:32852309-32852320 chr11:32852133-32852144 chr11:32852309-32852322
22	CEBPB	chr11:32851939-32852391	HepG2	liver:	n/a	chr11:32852309-32852320 chr11:32852133-32852144 chr11:32852309-32852322
23	CEBPB	chr11:32851813-32852506	MCF-7	breast:	n/a	chr11:32852309-32852320 chr11:32852133-32852144 chr11:32852309-32852322
24	CEBPB	chr11:32851942-32852327	K562	blood:	n/a	chr11:32852309-32852320 chr11:32852133-32852144 chr11:32852309-32852322
25	CEBPB	chr11:32851943-32852334	A549	lung:	n/a	chr11:32852309-32852320 chr11:32852133-32852144 chr11:32852309-32852322
26	CEBPB	chr11:32851940-32852322	HepG2	liver:	n/a	chr11:32852309-32852320 chr11:32852133-32852144 chr11:32852309-32852322
27	CEBPB	chr11:32851855-32852473	ECC-1	luminal epithelium:	n/a	chr11:32852309-32852320 chr11:32852133-32852144 chr11:32852309-32852322
28	CEBPB	chr11:32851833-32852432	HCT-116	colon:	n/a	chr11:32852309-32852320 chr11:32852133-32852144 chr11:32852309-32852322
29	CEBPD	chr11:32851902-32852222	HepG2	liver:	n/a	chr11:32852133-32852144
30	CEBPD	chr11:32851968-32852312	HepG2	liver:	n/a	chr11:32852133-32852144
31	CHD1	chr11:32850922-32851591	GM12878	blood:	n/a	n/a
32	CHD1	chr11:32851886-32852256	GM12878	blood:	n/a	n/a
33	CHD1	chr11:32851005-32851113	H1-hESC	embryonic stem cell:	n/a	n/a
34	CHD2	chr11:32851116-32852258	Hela-S3	cervix:	n/a	n/a
35	CHD2	chr11:32851587-32851812	H1-hESC	embryonic stem cell:	n/a	n/a
36	CTBP2	chr11:32851172-32852084	H1-hESC	embryonic stem cell:	n/a	n/a
37	CTCF	chr11:32851140-32851290	GM12873	blood:	n/a	n/a
38	CTCF	chr11:32851118-32851254	MCF-7	breast:	n/a	n/a
39	CTCF	chr11:32851120-32851270	HBMEC	blood vessel:	n/a	n/a
40	CTCF	chr11:32851900-32852050	GM06990	blood:	n/a	n/a
41	CTCF	chr11:32851157-32851281	Spleen_OC	spleen:	n/a	n/a
42	CTCF	chr11:32851116-32851198	MCF-7	breast:	n/a	n/a
43	CTCF	chr11:32851140-32851290	GM12867	blood:	n/a	n/a
44	CTCF	chr11:32851145-32851255	GM19238	blood:	n/a	n/a
45	CTCF	chr11:32851280-32851317	GM19240	blood:	n/a	n/a
46	CTCF	chr11:32851720-32851870	GM12866	blood:	n/a	n/a
47	CTCF	chr11:32851141-32851191	NHEK	skin:	n/a	n/a
48	CTCF	chr11:32851160-32851223	MCF-7	breast:	n/a	n/a
49	CTCF	chr11:32851120-32851270	GM12865	blood:	n/a	n/a
50	CTCF	chr11:32851080-32851230	AG09319	gingival:	n/a	n/a

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr11:32851240-32851290	SK-N-SH_RA	brain:	n/a
2	chr11:32851087-32851137	T-47D	breast:	n/a
3	chr11:32851240-32851290	T-47D	breast:	n/a
4	chr11:32851371-32851421	BJ	skin:	n/a
5	chr11:32851087-32851137	RPTEC	kidney:	n/a
6	chr11:32851087-32851137	PFSK-1	brain:	n/a
7	chr11:32851378-32851428	HCT-116	colon:	n/a
8	chr11:32851950-32852000	NT2-D1	testis:	n/a
9	chr11:32851240-32851290	NH-A	brain:	n/a
10	chr11:32851087-32851137	SK-N-SH_RA	brain:	n/a
11	chr11:32851346-32851396	NH-A	brain:	n/a
12	chr11:32851087-32851137	PrEC	prostate:	n/a
13	chr11:32851240-32851290	HRCEpiC	kidney:	n/a
14	chr11:32851177-32851227	LNCaP	prostate:	n/a
15	chr11:32851346-32851396	PANC-1	pancreas:	n/a
16	chr11:32851177-32851227	HUVEC	blood vessel:	n/a
17	chr11:32851950-32852000	GM12878	blood:	n/a
18	chr11:32851356-32851406	HL-60	blood:	n/a
19	chr11:32851371-32851421	SK-N-MC	brain:	n/a
20	chr11:32851371-32851421	HRE	kidney:	n/a
21	chr11:32851378-32851428	T-47D	breast:	n/a
22	chr11:32851356-32851406	HepG2	liver:	n/a
23	chr11:32851356-32851406	ovcar-3	ovarian:	n/a
24	chr11:32851378-32851428	GM12891	blood:	n/a
25	chr11:32851356-32851406	Jurkat	blood:	n/a
26	chr11:32851371-32851421	HCM	heart:	n/a
27	chr11:32851371-32851421	SK-N-SH	brain:	n/a
28	chr11:32851950-32852000	HRE	kidney:	n/a
29	chr11:32851177-32851227	RPTEC	kidney:	n/a
30	chr11:32851361-32851411	GM12878	blood:	n/a
31	chr11:32851361-32851411	PANC-1	pancreas:	n/a
32	chr11:32851260-32851310	MCF-7	breast:	n/a
33	chr11:32851177-32851227	K562	blood:	n/a
34	chr11:32851371-32851421	GM19239	blood:	n/a
35	chr11:32851346-32851396	NHDF-neo	bronchial:	n/a
36	chr11:32851950-32852000	CMK	blood:	n/a
37	chr11:32851371-32851421	PFSK-1	brain:	n/a
38	chr11:32851361-32851411	HRCEpiC	kidney:	n/a
39	chr11:32851087-32851137	HIPEpiC	eye:	n/a
40	chr11:32851240-32851290	A549	lung:	n/a
41	chr11:32851531-32851581	HepG2	liver:	n/a
42	chr11:32851378-32851428	CMK	blood:	n/a
43	chr11:32851346-32851396	ECC-1	luminal epithelium:	n/a
44	chr11:32851950-32852000	PrEC	prostate:	n/a
45	chr11:32851260-32851310	HL-60	blood:	n/a
46	chr11:32851378-32851428	HCM	heart:	n/a
47	chr11:32851378-32851428	HIPEpiC	eye:	n/a
48	chr11:32851371-32851421	HMEC	breast:	n/a
49	chr11:32851346-32851396	SK-N-SH_RA	brain:	n/a
50	chr11:32851371-32851421	HCT-116	colon:	n/a

No.	Distal block	Cell Line	Cell type
1	chr11:32850121..32852277-chr11:33088797..33091531,2	MCF-7	breast:
2	chr11:32850955..32851927-chr16:89752956..89753523,2	Hela-S3	cervix:
3	chr11:32850001..32854483-chr11:32912810..32915962,5	MCF-7	breast:
4	chr11:32851440..32852221-chr2:173420119..173420696,2	Hela-S3	cervix:
5	chr11:32849868..32852880-chr11:32911360..32916794,6	MCF-7	breast:
6	chr11:32851076..32851981-chr12:123011655..123012268,2	Hela-S3	cervix:
7	chr11:32851420..32852136-chr5:36606640..36607218,2	Hela-S3	cervix:
8	chr11:32851461..32852210-chr3:49058647..49059440,2	NB4	blood:
9	chr11:32851501..32854370-chr11:32879596..32881538,2	MCF-7	breast:

Variant related genes	Relation type
PRRG4	TF binding region
PRRG4	CpG island
ENSG00000260259	chromatin interactions
ENSG00000184445	chromatin interactions
ENSG00000176148	chromatin interactions
ENSG00000152256	chromatin interactions
ENSG00000185324	chromatin interactions
ENSG00000178057	chromatin interactions
ENSG00000178149	chromatin interactions
ENSG00000060749	chromatin interactions
ENSG00000079215	chromatin interactions

Extended variants
information (count: 75 )
Associated
traits (count: 79 )

Variant overlapped rSNPs/rCNVs (count:75 , 50 per page) page: 1 2

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs149159193	chr11:32849912-32849913	Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
2	rs552762098	chr11:32849913-32849914	Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
3	rs529020527	chr11:32849919-32849920	Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
4	rs369985090	chr11:32849963-32849964	Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
5	rs11032011	chr11:32849970-32849971	Weak transcription	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
6	rs139235669	chr11:32849971-32849972	Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
7	rs201310398	chr11:32850059-32850060	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
8	rs75031661	chr11:32850061-32850062	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
9	rs77104810	chr11:32850073-32850074	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
10	rs560704598	chr11:32850092-32850093	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
11	rs527432470	chr11:32850120-32850121	Weak transcription Enhancers	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
12	rs561841574	chr11:32850127-32850128	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
13	rs112058705	chr11:32850181-32850182	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
14	rs143221918	chr11:32850221-32850222	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
15	rs2900979	chr11:32850251-32850252	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
16	rs2900980	chr11:32850280-32850281	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
17	rs190044268	chr11:32850303-32850304	Weak transcription Enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
18	rs566820944	chr11:32850410-32850411	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
19	rs531195900	chr11:32850448-32850449	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
20	rs35883510	chr11:32850454-32850455	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
21	rs372844163	chr11:32850537-32850538	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
22	rs529376407	chr11:32850665-32850666	Flanking Bivalent TSS/Enh Weak transcription Bivalent/Poised TSS Active TSS Enhancers Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
23	rs549195591	chr11:32850796-32850797	Flanking Bivalent TSS/Enh Weak transcription Bivalent/Poised TSS Active TSS Enhancers Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
24	rs11032012	chr11:32850835-32850836	Bivalent/Poised TSS Enhancers Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	3 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
25	rs183344283	chr11:32850838-32850839	Bivalent/Poised TSS Enhancers Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
26	rs148172429	chr11:32850842-32850843	Bivalent/Poised TSS Enhancers Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
27	rs188921401	chr11:32850857-32850858	Bivalent/Poised TSS Enhancers Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
28	rs55744018	chr11:32850948-32850949	Bivalent/Poised TSS Enhancers Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	3 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
29	rs61889484	chr11:32850949-32850950	Bivalent/Poised TSS Enhancers Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
30	rs539028824	chr11:32850997-32850998	Bivalent/Poised TSS Enhancers Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
31	rs12363973	chr11:32851008-32851009	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS	TF binding region Chromatin interactive region	5 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
32	rs56119237	chr11:32851032-32851033	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS	TF binding region Chromatin interactive region	5 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
33	rs541942023	chr11:32851033-32851034	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
34	rs553699711	chr11:32851036-32851037	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
35	rs555642766	chr11:32851091-32851092	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS	TF binding region CpG island Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
36	rs116179632	chr11:32851093-32851094	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS	TF binding region CpG island Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
37	rs11032013	chr11:32851189-32851190	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS	TF binding region CpG island Chromatin interactive region	6 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
38	rs61889485	chr11:32851192-32851193	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS	TF binding region CpG island Chromatin interactive region	6 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
39	rs111778194	chr11:32851233-32851234	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
40	rs540304995	chr11:32851320-32851321	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
41	rs112220180	chr11:32851324-32851325	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
42	rs560518008	chr11:32851416-32851417	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers Transcr. at gene 5' and 3'	TF binding region CpG island Chromatin interactive region	6 gene(s)	Overlapped CNVs	n/a
43	rs11032014	chr11:32851448-32851449	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers Transcr. at gene 5' and 3'	TF binding region Chromatin interactive region	8 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
44	rs549023873	chr11:32851453-32851454	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers Transcr. at gene 5' and 3'	TF binding region Chromatin interactive region	8 gene(s)	Overlapped CNVs	n/a
45	rs61889486	chr11:32851484-32851485	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers Transcr. at gene 5' and 3'	TF binding region Chromatin interactive region	10 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
46	rs61889487	chr11:32851487-32851488	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers Transcr. at gene 5' and 3'	TF binding region Chromatin interactive region	10 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
47	rs571881014	chr11:32851497-32851498	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers Transcr. at gene 5' and 3'	Chromatin interactive region	9 gene(s)	Overlapped CNVs	n/a
48	rs534484931	chr11:32851503-32851504	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers Transcr. at gene 5' and 3'	Chromatin interactive region	9 gene(s)	Overlapped CNVs	n/a
49	rs139996204	chr11:32851538-32851539	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers Transcr. at gene 5' and 3'	Chromatin interactive region	9 gene(s)	Overlapped CNVs	n/a
50	rs546323987	chr11:32851550-32851551	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers Transcr. at gene 5' and 3'	Chromatin interactive region	9 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:79)

Disease	PMID	Source
Breast cancer	17603634	CNVD
Medulloblastoma	21979893	CNVD
Thyroid cancer	19087340	CNVD
Melanoma	18172304	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Wilms tumour	21544195	CNVD
Parathyroid adenoma	22454399	CNVD
Chordoma	21602918	CNVD
Breast cancer	21949216	CNVD
Cancer	21637783	CNVD
Non-syndromic sensorineural hearing loss	19222835	CNVD
T-cell acute lymphoblastic leukemia	20065082	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Endometrial cancer	22040021	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Beckwith-Wiedemann syndrome	21518781	CNVD
Wilms tumour	21518781	CNVD
Hepatoblastoma	21518781	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Gastrointestinal stromal cancer	17535989	CNVD
Paraganglioma	17535989	CNVD
Pulmonary chondroma	17535989	CNVD
Gastric cancer	17908304	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Multiple myeloma	20724749	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Autism	22495311	CNVD
Prostate cancer	18632612	CNVD
Lung cancer	18438408	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Non-small cell lung cancer	21385341	CNVD
Intellectual disability	22102821	CNVD
Breast cancer	21785460	CNVD
Medulloblastoma	16783165	CNVD
small cell lung cancer	20016488	CNVD
Renal cell carcinoma	18194544	CNVD
Potocki-Shaffer syndrome	19222835	CNVD
WAGR syndrome	19222835	CNVD
Chordoma	18071362	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Chronic lymphocytic leukemia	20421269	CNVD
Breast cancer	21364760	CNVD
Glioblastoma multiforme	22286061	CNVD
Aniridia syndrome	21572526	CNVD
Myelofibrosis	22110671	CNVD
Breast cancer	16272173	CNVD
Retinoblastoma	22278416	CNVD
Denys-drash syndrome	21085971	CNVD
T-cell acute lymphoblastic leukemia	18185524	CNVD
WAGR syndrome	16773131	CNVD
Disorders of sex development	22290220	CNVD
Aniridia syndrome	17204608	CNVD
Mental retardation	17204608	CNVD
WAGR syndrome	19617690	CNVD
genitourinary abnormalities	17204608	CNVD
Breast cancer	16397240	CNVD
Mental retardation	16773131	CNVD
Multiple myeloma	16616336	CNVD
Cancer	17160897	CNVD
Cancer	21183584	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
WAGR syndrome	22470819	CNVD
Neurodevelopmental disorder	22521361	CNVD
Denys-drash syndrome	19566914	CNVD
Familial wilms tumor	19566914	CNVD
Frasier syndrome	19566914	CNVD
Non-small cell lung cancer	21829676	CNVD
WAGR syndrome	20603712	CNVD
Autism	17322880	CNVD
Renal cell carcinoma	18765545	CNVD
Breast cancer	21858162	CNVD
Cancer	20164920	CNVD
Breast cancer	16620391	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
Ependymoma	20639864	CNVD

Chromatin state (count:318 , 50 per page) page: 1 2 3 4 5 6 7

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr11:32837400-32850800	Weak transcription	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
2	chr11:32840000-32850200	Weak transcription	Liver	Liver
3	chr11:32843200-32850800	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
4	chr11:32843600-32850200	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Female	--
5	chr11:32843800-32850600	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
6	chr11:32844000-32850000	Weak transcription	Hela-S3	cervix
7	chr11:32844000-32850400	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
8	chr11:32846400-32850400	Weak transcription	Primary monocytes fromperipheralblood	blood
9	chr11:32846400-32850400	Weak transcription	Monocytes-CD14+_RO01746	blood
10	chr11:32846600-32850400	Weak transcription	Primary neutrophils fromperipheralblood	blood
11	chr11:32846800-32850400	Weak transcription	Foreskin Keratinocyte Primary Cells skin03	Skin
12	chr11:32848200-32850400	Weak transcription	Pancreatic Islets	Pancreatic Islet
13	chr11:32849200-32850600	Weak transcription	Foreskin Melanocyte Primary Cells skin03	Skin
14	chr11:32849400-32850800	Weak transcription	Primary T helper naive cells fromperipheralblood	blood
15	chr11:32850000-32850400	Enhancers	Hela-S3	cervix
16	chr11:32850000-32850400	Weak transcription	NHEK	skin
17	chr11:32850200-32850400	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
18	chr11:32850200-32850400	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
19	chr11:32850200-32850600	Enhancers	Liver	Liver
20	chr11:32850200-32850600	Enhancers	GM12878-XiMat	blood
21	chr11:32850400-32850600	Bivalent Enhancer	iPS-15b Cell Line	embryonic stem cell
22	chr11:32850400-32850600	Enhancers	Breast Myoepithelial Primary Cells	Breast
23	chr11:32850400-32850600	Enhancers	Primary monocytes fromperipheralblood	blood
24	chr11:32850400-32850600	Enhancers	Primary hematopoietic stem cells	blood
25	chr11:32850400-32850600	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
26	chr11:32850400-32850600	Enhancers	Duodenum Mucosa	Duodenum
27	chr11:32850400-32850600	Flanking Active TSS	Pancreatic Islets	Pancreatic Islet
28	chr11:32850400-32850600	Flanking Active TSS	Hela-S3	cervix
29	chr11:32850400-32850600	Enhancers	Monocytes-CD14+_RO01746	blood
30	chr11:32850400-32850600	Flanking Active TSS	NHEK	skin
31	chr11:32850400-32850800	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
32	chr11:32850400-32850800	Enhancers	Primary neutrophils fromperipheralblood	blood
33	chr11:32850400-32850800	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Male	--
34	chr11:32850400-32850800	Enhancers	Colon Smooth Muscle	Colon
35	chr11:32850400-32850800	Enhancers	Duodenum Smooth Muscle	Duodenum
36	chr11:32850400-32850800	Active TSS	Fetal Intestine Large	intestine
37	chr11:32850400-32850800	Enhancers	Fetal Intestine Small	intestine
38	chr11:32850400-32850800	Enhancers	Stomach Mucosa	stomach
39	chr11:32850400-32851000	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Female	--
40	chr11:32850400-32851800	Active TSS	HMEC	breast
41	chr11:32850600-32850800	Flanking Bivalent TSS/Enh	ES-I3 Cell Line	embryonic stem cell
42	chr11:32850600-32850800	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
43	chr11:32850600-32850800	Bivalent Enhancer	Primary B cells from cord blood	blood
44	chr11:32850600-32850800	Enhancers	Primary hematopoietic stem cells short term culture	blood
45	chr11:32850600-32850800	Enhancers	Primary T helper memory cells from peripheral blood 2	blood
46	chr11:32850600-32850800	Bivalent Enhancer	Primary T helper cells fromperipheralblood	blood
47	chr11:32850600-32850800	Active TSS	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
48	chr11:32850600-32850800	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
49	chr11:32850600-32850800	Enhancers	Adipose Nuclei	Adipose
50	chr11:32850600-32850800	Enhancers	Rectal Mucosa Donor 31	rectum

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links